New metformin derivative HL156A prevents oral cancer progression by inhibiting the insulin-like growth factor/AKT/mammalian target of rapamycin pathways.

导出 OA

翻译打印收藏纠错

第一作者： Thuy Giang,Lam

第一单位： Department of Pathology, College of Dentistry, Chosun University, Gwangju, South Korea.

作者： Thuy Giang,Lam ^[1] ; Yun Soo,Jeong ^[1] ; Soo-A,Kim ^[2] ; Sang-Gun,Ahn ^[1]

作者单位： Department of Pathology, College of Dentistry, Chosun University, Gwangju, South Korea. ^[1] Department of Biochemistry, College of Oriental Medicine, Dongguk University, Gyeongju, South Korea. ^[2]

关键词 HL156A metformin derivative migration mitochondrial membrane potential oral cancer

主题词动物(Animals);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);细胞存活(Cell Survival);疾病恶化(Disease Progression);剂量效应关系, 药物(Dose-Response Relationship, Drug);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);胍类(Guanidines);人类(Humans);小鼠(Mice);口腔肿瘤(Mouth Neoplasms);原癌基因蛋白质c-akt(Proto-Oncogene Proteins c-akt);吡咯烷类(Pyrrolidines);信号传导(Signal Transduction);生长调节素类(Somatomedins);TOR丝氨酸-苏氨酸激酶(TOR Serine-Threonine Kinases);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)

DOI 10.1111/cas.13482

PMID 29285837

发布时间 2022-03-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Cancer science

2018年109卷3期

699-709页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

New metformin derivative HL156A prevents oral cancer progression by inhibiting the insulin-like growth factor/AKT/mammalian target of rapamycin pathways.

Cancer science

相似文献

Cancer science

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

New metformin derivative HL156A prevents oral cancer progression by inhibiting the insulin-like growth factor/AKT/mammalian target of rapamycin pathways.

Cancer science

相似文献

Cancer science

相关期刊

检索历史清除